This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Questcor Pharmaceuticals Inc (QCOR)

NASDAQ: Health Care

$91.60 -0.97 | -1.05%
07/09/14 - 4:00 PM ET
  • Prev Close: 92.57
  • Day's Open: 92.37
  • Volume: 984.08K
  • Avg Vol: 1.80M
  • Shares Outstanding: 60.98M
  • Mkt Cap: 5.72B
  • Div: $0.30
  • Div Yield: 1.30%
  • P/E: 17.66
  • EPS: 4.99
QCOR Day's Range
$91.09
$93.54
QCOR 52 Week Range
$45.41
$96.44
QCOR Business Summary
Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides drugs for the treatment of autoimmune and inflammatory disorders. The company primarily offers H.P.View QCOR key stats
QCOR Performance as of Prev. Close
YTD
70.01%
3-Mo
14.64%
1-Yr
97.38%
3-Yr
234.07%
QCOR EPS Performance
1-Yr Ago
4.99
2-Yrs Ago
3.28
3-Yrs Ago
1.27
QCOR Percentage in these ETFs
0.260%
0.160%
0.045%
0.040%
0.032%
QCOR News

QCOR Questcor Pharmaceuticals Inc

Analysts Ratings for QCOR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 3 4
Moderate Buy 0 0 0 0
Hold 4 4 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET QCOR ANALYST REPORT

Brokerage Partners

QCOR Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs